Insider · CIK 0001579988
R. Erik Holmlin
ceopresidentofficerdirector
Files at BNGO (Bionano Genomics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -51 | $1.10 | $56 | 1,657 | Feb 18, 2026 |
| Feb 2, 2026 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +69,484 | $0.00 | $0 | 69,484 | Feb 4, 2026 |
| Jun 3, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -75 | $3.69 | $277 | 1,708 | Jun 3, 2025 |
| Mar 14, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -198 | $3.47 | $687 | 1,783 | Mar 18, 2025 |
| Mar 14, 2025 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,449 | $0.00 | $0 | 17,449 | Mar 18, 2025 |
| Feb 15, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -51 | $5.73 | $292 | 1,981 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.